IGKV1D-22 and neoplasm: In view of the facilitation of drug resistance by S100A8/A9, S100A8/A9 antagonists might be developed to increase the vulnerability of tumor cells to chemotherapy, and the combined use of autophagy inhibitors might have excellent therapeutic effects.